跳至主要内容
临床试验/IRCT20190406043175N5
IRCT20190406043175N5尚未招募2 期

Clinical trial of Portulaca oleracea extract capsule on clinical indicators of osteoarthritis

Mashhad University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 80 years(—)
性别
All

入选标准

  • Initial symptomatic osteoarthritis in at least one knee by clinical or radiological criteria ACR (American College of Rheumatology) is approved
  • Lack of proper adherence to routine drug treatment (meloxicam tablets) for at least two weeks before the study
  • Score higher than 30 at baseline VAS scale

排除标准

  • The intra-articular injection of hyaluronic acid in the three months before the start of the study
  • The 4-week treatment with oral corticosteroids before the start of the study
  • Patients with a history of deep vein thrombosis
  • Active liver or renal disease and malignancies
  • Secondary osteoarthritis or suspected
  • Patients treated with hormonal drugs
  • Patients treated with anticoagulation drugs
  • Patients with a history of ischemic or hemorrhagic stroke

研究者

相似试验